Philip A. Sobol
Direktor/Vorstandsmitglied bei S&B Surgery Center
Profil
Dr. Philip A.
Sobol, MD, is a Managing Director at Sobol Orthopedic Medical Group.
He is on the Board of Directors at Entia Biosciences, Inc. and S&B Surgery Center.
Dr. Sobol was previously employed as an Assistant Clinical Professor by University of Southern California.
He also served on the board at Cordex Pharma, Inc.
He received his undergraduate degree from the University of Rochester and a doctorate degree from the University of Southern California.
Aktive Positionen von Philip A. Sobol
| Unternehmen | Position | Beginn |
|---|---|---|
Sobol Orthopedic Medical Group
 Sobol Orthopedic Medical Group Medical/Nursing ServicesHealth Services Sobol Orthopedic Medical Group provides chiropractic services. | Corporate Officer/Principal | - |
| S&B Surgery Center | Direktor/Vorstandsmitglied | 01.01.2004 |
Ehemalige bekannte Positionen von Philip A. Sobol
| Unternehmen | Position | Ende |
|---|---|---|
| ENTIA BIOSCIENCES, INC. | Direktor/Vorstandsmitglied | 03.12.2015 |
University of Southern California
 University of Southern California Other Consumer ServicesConsumer Services University of Southern California is a private research university that mainly offers undergraduate, graduate & other higher education. The university was founded in 1880 and is headquartered in Los Angeles, CA. | Corporate Officer/Principal | 01.01.1993 |
Cordex Pharma, Inc.
 Cordex Pharma, Inc. Medical SpecialtiesHealth Technology Cordex Pharma, Inc. is a specialty pharmaceutical company that develops new cardiovascular medicines based upon the emerging pharmacology of adenosine 5'-triphosphate (ATP) and nitric oxide (NO). These two molecules play critical roles in cellular metabolism and signal transduction, the manipulation of which constitute novel therapeutic modalities for the treatment of major cardiovascular disorders. Cordex Pharma was founded on February 9, 1996 and is headquartered in Philadelphia, PA. | Direktor/Vorstandsmitglied | - |
Ausbildung von Philip A. Sobol
| Rochester Christian University | Undergraduate Degree |
| University of Southern California | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ENTIA BIOSCIENCES, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Cordex Pharma, Inc.
Cordex Pharma, Inc. Medical SpecialtiesHealth Technology Cordex Pharma, Inc. is a specialty pharmaceutical company that develops new cardiovascular medicines based upon the emerging pharmacology of adenosine 5'-triphosphate (ATP) and nitric oxide (NO). These two molecules play critical roles in cellular metabolism and signal transduction, the manipulation of which constitute novel therapeutic modalities for the treatment of major cardiovascular disorders. Cordex Pharma was founded on February 9, 1996 and is headquartered in Philadelphia, PA. | Health Technology |
Sobol Orthopedic Medical Group
Sobol Orthopedic Medical Group Medical/Nursing ServicesHealth Services Sobol Orthopedic Medical Group provides chiropractic services. | Health Services |
| S&B Surgery Center |
